Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma. Typically, diagnosing skin cancer starts with a visual inspection. Monthly self-examinations and annual physician visits are advised by the Skin Cancer Foundation and the American Cancer Society to screen for possible skin cancer. If a suspicious spot is identified, the area will first be examined by the doctor, observing its scale, shape, colour and texture, and any bleeding or scaling. Biopsies and imaging scans are the two most common forms of tests used in diagnosing skin cancer. There are many different types of biopsy, but an excisional biopsy in which the doctor extracts all growth is always enough to treat skin cancer. It is more probable that melanoma and Merkel cell carcinoma will spread. In these cases it is possible to use one of many medical imaging techniques to assess if cancer cells have metastasized to internal organs and bones. Procedures for imaging include: CT scan, X-ray, and MRI.
MARKET DYNAMICS
Factors driving the growth of the skin cancer market are the growing incidence of skin cancer, coupled with increasing awareness about skin cancer. However, the high cost associated with diagnosis and treatment is expected to hamper the growth of the market. Moreover, increasing extensive R&D by market players is anticipated to boost the market growth.
MARKET SCOPE
The "Skin Cancer Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of skin cancer market with detailed market segmentation by cancer type and type. The skin cancer market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in skin cancer market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The skin cancer market is segmented on the basis of cancer type and type. Based on cancer type, the market is segmented as melanoma and non-melanoma. On the basis of type, the market is categorized as diagnosis and therapeutics. The diagnosis type is sub segmented as dermatoscopy, biopsy, genetic tests, and others. Therapeutics segment is further sub segmented as chemotherapy, immunotherapy, targeted therapy, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the skin cancer market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The skin cancer market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting skin cancer market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the skin cancer market in these regions.
MARKET PLAYERS
The report covers key developments in the skin cancer market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from skin cancer market are anticipated to have lucrative growth opportunities in the future with the rising demand for skin cancer in the global market. Below mentioned is the list of few companies engaged in the skin cancer market.
The report also includes the profiles of key players in skin cancer market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Abbott Laboratories
- Amgen, Inc.
- Merck & Co., Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Sanofi S.A.
- Qiagen NV
Sun Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.